Salmonella-mediated gene therapy in experimental colitis in mice

Experimental Biology and Medicine

Volumn 236, Issue 2, 2011, Pages 177-183

  Palffy, Roland ^a,b   Gardlik, Roman ^a,b   Behuliak, Michal ^a,b   Jani, Peter ^c   Balakova, Denisa ^b   Kadasi, Ludevit ^b,d   Turna, Jan ^b   Celec, Peter ^a,b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c Hospital Krnov   (Czech Republic)

^d INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

Bactofection; Crohn's disease; Gene therapy; Oxidative stress; Ulcerative colitis

Indexed keywords

AMPICILLIN; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; DEXTRAN SULFATE; DRINKING WATER; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID DNA; STREPTOMYCIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; ENTERITIS; FECES; FLUID INTAKE; FOOD INTAKE; GENE THERAPY; LIPID PEROXIDATION; MALE; MONOCYTE; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM;

ANIMALS; CHEMOKINE CCL2; COLITIS; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GENE THERAPY; HISTOCYTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; SALMONELLA TYPHIMURIUM; SUPEROXIDE DISMUTASE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 79951596110     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010277     Document Type: Article

References (35)

1. Wong A, Bass D. Laboratory evaluation of inflammatory bowel disease. Curr Opin Pediatr 2008;20:566-70
2. Sandborn WJ. Therapy for Crohn disease. Curr Opin Gastroenterol 2000;16:318-23 (Pubitemid 32260401)
3. Zhang H, Massey D, Tremelling M, Parkes M. Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull 2008;87:17-30
4. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-55
5. Dignass AU, Baumgart DC, Sturm A. Review article: the aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms. Aliment Pharmacol Ther 2004;20 (Suppl 4):9-17 (Pubitemid 39319241)
6. Herfarth H, Goke M, Hellerbrand C, Muhlbauer M, Vogl D, Scholmerich J, Rogler G. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int J Colorectal Dis 2003;18:401-5 (Pubitemid 37062730)
7. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med 1995;19:911-8
8. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86 (Pubitemid 26366811)
9. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007;59:1073-83 (Pubitemid 47615208)
10. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803 (Pubitemid 19057602)
11. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993;75:263-74 (Pubitemid 23320290)
12. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000;62:240-8
13. Rochat T, Bermudez-Humaran L, Gratadoux JJ, Fourage C, Hoebler C, Corthier G, Langella P. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact 2007;6:22
14. Marshall D, Cameron J, Lightwood D, Lawson AD. Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis. Inflamm Bowel Dis 2007;13:219-24 (Pubitemid 46806231)
15. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997;91:765-75 (Pubitemid 28007733)
16. Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 2002;62:1205-12 (Pubitemid 34160310)
17. Ikeda Y, Yonemitsu Y, Kataoka C, Kitamoto S, Yamaoka T, Nishida K, Takeshita A, Egashira K, Sueishi K. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 2002;283:H2021-8
18. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998;114:385-91 (Pubitemid 28539597)
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75
20. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85 (Pubitemid 38314881)
21. David AL, Peebles DM, Gregory L, Waddington SN, Themis M, Weisz B, Ruthe A, Lawrence L, Cook T, Rodeck CH, Coutelle C. Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases. Hum Gene Ther 2006;17:767-79 (Pubitemid 44100721)
22. Wirtz S, Galle PR, Neurath MF. Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure. Gut 1999;44:800-7 (Pubitemid 29244214)
23. Giladi E, Raz E, Karmeli F, Okon E, Rachmilewitz D. Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats. Eur J Gastroenterol Hepatol 1995;7:341-7
24. Lindsay J, Van C, Brennan F, Van S, Drillenburg P, Hodgson H, Te A, Sol M. IL-10 gene therapy prevents TNBS-induced colitis. Gene Ther 2002;9:1715-21 (Pubitemid 36104616)
25. Loessner H, Weiss S. Bacteria-mediated DNA transfer in gene therapy and vaccination. Expert Opin Biol Ther 2004;4:157-68 (Pubitemid 38200429)
26. Fu GF, Li X, Hou YY, Fan YR, Liu WH, Xu GX. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther 2005;12:133-40 (Pubitemid 40205095)
27. Castagliuolo I, Beggiao E, Brun P, Barzon L, Goussard S, Manganelli R, Grillot-Courvalin C, Palu G. Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 2005;12:1070-8 (Pubitemid 40946149)
28. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. Treatment of murine colitits by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-5 (Pubitemid 30656052)
29. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541-6 (Pubitemid 47040018)
30. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009;461:1282-6
31. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 1998;42:485-92 (Pubitemid 28186563)
32. Niemela O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 2001;31:1533-8 (Pubitemid 34024975)
33. Steidler L. Genetically engineered probiotics. Best Pract Res Clin Gastroenterol 2003;17:861-76
34. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-91
35. Kokesova A, Frolova L, Kverka M, Sokol D, Rossmann P, Bartova J, Tlaskalova-Hogenova H. Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiol (Praha) 2006;51:478-84 (Pubitemid 44807756)